Achema middle east

News

The Latest Breakthroughs in Dental Treatments

Dental care has moved well beyond fillings and routine cleanings. In the past few years, the field has seen fast-moving advances across regenerative medicine, digital manufacturing, artificial intelligence (AI) and minimally invasive therapies. These breakthroughs promise better diagnostics, faster...

How Can Digital Tools Improve Medication Adherence in Patients?

Medication adherence has long been one of healthcare’s toughest challenges. Even the most effective treatment plan fails if patients don’t take their medications consistently. This isn’t just a patient-level problem, though; it has massive implications for healthcare systems, pharmaceutical...

Russia, Vietnam Collaborate on Biopharma Technology Transfer

Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam. It is well to be noted that this agreement was officially concluded at a signing...

Trump Order to Go Heavy on D2C Pharmaceutical Ads

US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025. This push, which happens to...

Is US Planning Executive Order on Chinese Pharma Companies?

It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...

The Realities of the Nursing Shortage in Rural America

Along with multiple public health crises, the United States is also facing a nursing shortage, especially in rural parts of America. This problem is also exacerbated by rising costs, turnover, and competition in recruiting healthcare professionals. The factors contributing...

Green List by FDA to Cut Illegal GLP-1 Active Ingredients

The U.S. Food and Drug Administration has gone on to create a green list import alert in order to stop unapproved as well as unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering into the United States. Because of the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »